Table of Contents

1 Product Introduction and Overview

• 1.1 Product Definition
• 1.2 Product Specification
• 1.3 Global Market Overview
  • 1.3.1 Global Targeted Delivery Drugs Market Status and Forecast (2017-2028)
  • 1.3.2 Global Targeted Delivery Drugs Sales Value CAGR by Region
• 1.4 Market Drivers, Inhibitors
  • 1.4.1 Market Drivers
  • 1.4.2 Market Inhibitors
  • 1.4.3 COVID-19 Impact Analysis

2 Global Targeted Delivery Drugs Supply by Company

• 2.1 Global Targeted Delivery Drugs Sales Value by Company
• 2.2 Targeted Delivery Drugs Sales Area of Main Manufacturers
• 2.3 Trend of Concentration Rate

3 Global and Regional Targeted Delivery Drugs Market Status by Type

• 3.1 Targeted Delivery Drugs Type Introduction
  • 3.1.1 Ocular Drug Delivery
  • 3.1.2 Pulmonary Drug Delivery
  • 3.1.3 Drug Eluting Stents
  • 3.1.4 Other
• 3.2 Global Targeted Delivery Drugs Market by Type
• 3.3 North America: by Type
• 3.4 Europe: by Type
• 3.5 Asia Pacific: by Type
• 3.6 Central & South America: by Type
• 3.7 Middle East & Africa: by Type

4 Global and Regional Targeted Delivery Drugs Market Status by Application

• 4.1 Targeted Delivery Drugs Segment by Application
  • 4.1.1 Hospital
  • 4.1.2 Clinic
  • 4.1.3 Other
• 4.2 Global Targeted Delivery Drugs Market by Application
• 4.3 North America: by Application
• 4.4 Europe: by Application
• 4.5 Asia Pacific: by Application
• 4.6 Central & South America: by Application
• 4.7 Middle East & Africa: by Application

5 Global Targeted Delivery Drugs Market Status by Region

• 5.1 Global Targeted Delivery Drugs Market by Region
• 5.2 North America Targeted Delivery Drugs Market Status
• 5.3 Europe Targeted Delivery Drugs Market Status
• 5.4 Asia Pacific Targeted Delivery Drugs Market Status
• 5.5 Central & South America Targeted Delivery Drugs Market Status
• 5.6 Middle East & Africa Targeted Delivery Drugs Market Status

6 North America Targeted Delivery Drugs Market Status

• 6.1 North America Targeted Delivery Drugs Market by Country
• 6.2 United States
• 6.3 Canada
• 6.4 Mexico

7 Europe Targeted Delivery Drugs Market Status

• 7.1 Europe Targeted Delivery Drugs Market by Country
• 7.2 Germany
• 7.3 France
• 7.4 UK
• 7.5 Italy
• 7.6 Russia
• 7.7 Spain

8 Asia Pacific Targeted Delivery Drugs Market Status

• 8.1 Asia Pacific Targeted Delivery Drugs Market by Country
• 8.2 China
• 8.3 Japan
• 8.4 Korea
• 8.5 Southeast Asia
• 8.6 India
• 8.7 Australasia

9 Central & South America Targeted Delivery Drugs Market Status

• 9.1 Central & South America Targeted Delivery Drugs Market by Country
• 9.2 Brazil
• 9.3 Argentina
• 9.4 Colombia

10 Middle East & Africa Targeted Delivery Drugs Market Status

• 10.1 Middle East & Africa Targeted Delivery Drugs Market by Country
• 10.2 Iran
• 10.3 Israel
• 10.4 Turkey
• 10.5 South Africa
• 10.8 Saudi Arabia

11 Major Downstream Customers Analysis

• 11.1 Customer One Analysis
• 11.2 Customer Two Analysis
• 11.3 Customer Three Analysis
• 11.4 Customer Four Analysis

12 Global Targeted Delivery Drugs Market Forecast by Type and by Application

• 12.1 Global Targeted Delivery Drugs Sales Value Forecast (2023-2028)
• 12.2 Global Targeted Delivery Drugs Forecast by Type
• 12.3 Global Targeted Delivery Drugs Forecast by Application

13 Global Targeted Delivery Drugs Market Forecast by Region/Country

• 13.1 Global Targeted Delivery Drugs Market Forecast by Region (2023-2028)
• 13.2 North America Market Forecast
• 13.3 Europe Market Forecast
• 13.4 Asia Pacific Market Forecast
• 13.5 Central & South America Market Forecast
• 13.6 Middle East & Africa Market Forecast

14 Key Participants Company Information

• 14.1 Windtree Therapeutics
  • 14.1.1 Company Information
  • 14.1.2 Targeted Delivery Drugs Product Introduction
  • 14.1.3 Windtree Therapeutics Targeted Delivery Drugs Sales Value, Gross Margin and Global Share (2020-2022)
  • 14.1.4 SWOT Analysis
• 14.2 Roche
  • 14.2.1 Company Information
  • 14.2.2 Targeted Delivery Drugs Product Introduction
  • 14.2.3 Roche Targeted Delivery Drugs Sales Value, Gross Margin and Global Share (2020-2022)
  • 14.2.4 SWOT Analysis
• 14.3 Ra Pharma
  • 14.3.1 Company Information
  • 14.3.2 Targeted Delivery Drugs Product Introduction
  • 14.3.3 Ra Pharma Targeted Delivery Drugs Sales Value, Gross Margin and Global Share (2020-2022)
  • 14.3.4 SWOT Analysis
• 14.4 MultiVir
  • 14.4.1 Company Information
  • 14.4.2 Targeted Delivery Drugs Product Introduction
  • 14.4.3 MultiVir Targeted Delivery Drugs Sales Value, Gross Margin and Global Share (2020-2022)
  • 14.4.4 SWOT Analysis
• 14.5 Mankind Pharma
  • 14.5.1 Company Information
  • 14.5.2 Targeted Delivery Drugs Product Introduction
  • 14.5.3 Mankind Pharma Targeted Delivery Drugs Sales Value, Gross Margin and Global Share (2020-2022)
  • 14.5.4 SWOT Analysis
• 14.6 Lipocine
  • 14.6.1 Company Information
  • 14.6.2 Targeted Delivery Drugs Product Introduction
  • 14.6.3 Lipocine Targeted Delivery Drugs Sales Value, Gross Margin and Global Share (2020-2022)
  • 14.6.4 SWOT Analysis
• 14.7 Keystone Nano
  • 14.7.1 Company Information
  • 14.7.2 Targeted Delivery Drugs Product Introduction
  • 14.7.3 Keystone Nano Targeted Delivery Drugs Sales Value, Gross Margin and Global Share (2020-2022)
  • 14.7.4 SWOT Analysis
• 14.8 Immunocore
  • 14.8.1 Company Information
  • 14.8.2 Targeted Delivery Drugs Product Introduction
  • 14.8.3 Immunocore Targeted Delivery Drugs Sales Value, Gross Margin and Global Share (2020-2022)
  • 14.8.4 SWOT Analysis
• 14.9 Bayer
  • 14.9.1 Company Information
  • 14.9.2 Targeted Delivery Drugs Product Introduction
  • 14.9.3 Bayer Targeted Delivery Drugs Sales Value, Gross Margin and Global Share (2020-2022)
  • 14.9.4 SWOT Analysis
• 14.10 Arrowhead Pharmaceuticals
  • 14.10.1 Company Information
  • 14.10.2 Targeted Delivery Drugs Product Introduction
  • 14.10.3 Arrowhead Pharmaceuticals Targeted Delivery Drugs Sales Value, Gross Margin and Global Share (2020-2022)
  • 14.10.4 SWOT Analysis
• 14.11 Adverum

15 Conclusion

16 Methodology

This report provides a comprehensive analysis of current global Targeted Delivery Drugs market based on segmented types and downstream applications. Major product development trends are discussed under major downstream segment scenario.This report also focuses on major driving factors and inhibitors that affect the market and competitive landscape. Global and regional leading players in the Targeted Delivery Drugs industry are profiled in a detailed way, with sales data and market share info. This report also includes global and regional market size and forecast, drill-down to top 20 economies.

According to GRD Survey, the global Targeted Delivery Drugs market is estimated at $ million in 2021, and projected to grow at a CAGR of % to $ million by 2028.

Covid-19 pandemic has impacted the supply and demand status for many industries along the supply chain. Global Targeted Delivery Drugs Market Opportunities and Forecast 2023-2028 report makes a brilliant attempt to unveil key opportunities available in the global Targeted Delivery Drugs market under the Covid-19 impact to help readers in achieving a better market position. No matter the client is industry insider, potential entrant or investor, the report will provide useful data and information.

The Global Targeted Delivery Drugs Market has been exhibited in detail in the following chapters
Chapter 1 displays the basic product introduction and market overview.
Chapter 2 provides the competition landscape of global Targeted Delivery Drugs industry.
Chapter 3 provides the market analysis by type and by region
Chapter 4 provides the market analysis by application and by region
Chapter 5-10 presents regional and country market size and forecast, under the context of market drivers and inhibitors analysis.
Chapter 11 analyses the supply chain, including process chart introduction, upstream key raw material and cost analysis, distributor and downstream buyer analysis.
Chapter 12 provides the market forecast by type and by application
Chapter 13 provides the market forecast by region
Chapter 14 profies global leading players with their revenue, market share, profit margin, major product portfolio and SWOT analysis.
Chapter 15 conclusions

Segmented by Type
Ocular Drug Delivery
Pulmonary Drug Delivery
Drug Eluting Stents
Other

Segmented by Application
Hospital
Clinic
Other

Segmented by Country
North America
United States
Canada
Mexico
Europe
Germany
France
UK
Italy
Russia
Spain
Asia Pacific
China
Japan
Korea
Southeast Asia
India
Australasia
Central & South America
Brazil
Argentina
Colombia
Middle East & Africa
Iran
Israel
Turkey
South Africa
Saudi Arabia

Key manufacturers included in this survey
Windtree Therapeutics
Roche
Ra Pharma
MultiVir
Mankind Pharma
Lipocine
Keystone Nano
Immunocore
Bayer
Arrowhead Pharmaceuticals
Adverum